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Abstract
Background: Hepatic vein thrombosis (Budd-Chiari Syndrome) is a rare disorder resulting from
an obstruction to the outflow of blood from the liver. Early decompression is needed to prevent
liver dysfunction and death. Radiological intervention includes angioplasty of stenosis and webs and
the placement of transjugular intrahepatic portosystemic shunts (TIPPS). Side-to-side portacaval
shunt (SSPCS) remains the gold standard for achieving good long-term results.
Case presentation: A 37-year old lady underwent side-to-side portacaval shunt for Budd Chiari
syndrome. She had early shunt blockage and this was successfully treated with the placement of a
metallic stent across the shunt.
Conclusion: At five years, she remains asymptomatic, with normal liver functions, no ascites, and
normal flow through the stent on Colour Doppler examination.
Background
Budd-Chiari syndrome is characterized by hepatic venous
outflow obstruction, which often leads to death as a result
of portal hypertension and liver failure. Patients with
membranous occlusion of the major hepatic veins can be
treated by percutaneous placement of a metallic stent via
a transjugular or transhepatic approach [1]. In patients
with a significant caval obstruction caused by a hypertro-
phied caudate lobe, a metallic vascular stent can be placed
in the narrowed tract of the inferior vena cava, before
shunt surgery, by means of a transfemoral or transjugular
venous approach [1]. Side to side portacaval shunts have
excellent long-term results and remain the procedure of
choice in some units [2]. Stents can also be used to main-
tain the patency of surgical shunts that have been made to
bypass the obstruction to the blood flow from the
splanchnic circulation to the inferior vena cava via the
liver. We report a long term follow up of stent angioplasty
of a narrowed porta caval shunt in a patient with Budd
Chiari Syndrome.
Case presentation
A thirty seven year old female presented with a history of
progressive distension of the abdomen with pedal edema
and yellow discolouration of the eyes of two weeks dura-
tion. On examination she was found to be icteric with an
enlarged, firm liver and gross ascites. Liver function tests
revealed a conjugated hyperbilirubinemia with mildly
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deranged transaminases and alkaline phosphatase. Ultra-
sonography (USG) with Colour Doppler showed an
enlarged liver with a hypertrophied caudate lobe, a 1.1 cm
portal vein with hepatopetal flow, an occluded right
hepatic vein with middle and left hepatic veins patent
only in their proximal parts and a patent but narrowed
inferior vena cava, compressed by the caudate lobe,
together with free fluid in the abdomen. Splenic and supe-
rior mesenteric veins were normal. Liver biopsy confirmed
the diagnosis of Budd Chiari syndrome. Prothrombotic
workup did not reveal any obvious cause for the Budd
Chiari syndrome.
Transjugular venogram showed 90% narrowing of the IVC
with a 14 mmHg gradient across the narrowing and non-
visualization of the hepatic veins beyond their origins.
The hepatic veins could not be cannulated, suggestive of
complete occlusion at the ostia. (Figure 1:A). An 18 × 63
mm WALL STENT was placed across the narrowed seg-
ment in the IVC followed by balloon dilatation using a 16
mm balloon (Figure 1:B).
Percutaneous transhepatic venogram through the left
hepatic vein under USG guidance showed the left hepatic
vein was patent only in its proximal portion, the distal 2–
3 cms being completely occluded and draining through
multiple collaterals. IVC stent was in situ (Figure 2). The
right hepatic vein was completely occluded. The middle
hepatic vein also showed long-segment total occlusion (>
3 cm).
Recanalisation of the left hepatic vein was attempted, but
failed owing to the long and fibrous nature of the occlu-
sion. The patient then underwent a side-to-side portocaval
shunt using the right external iliac vein as H-graft. Postop-
erative recovery was uneventful and she was anticoagu-
lated during that time. Six weeks after surgery, she was re-
admitted with pedal edema and ascites. Doppler evalua-
tion showed patchy flow through the shunt. Venogram
through a transjugular approach revealed patent IVC
stent. There was narrowing of the portosystemic graft with
a gradient of more than 15 mmHg near its IVC end (Figure
3:A, B).
Considering the acute angulation of the portocaval shunt
with the IVC, a transfemoral venous approach for veno-
plasty and stenting was thought to be more appropriate.
Following predilatation of the graft with a 5 mm angi-
oplasty balloon (Figure 4A), an 8 mm × 30 mm self-
expanding nitinol stent was placed in the graft covering its
portal and caval ends. Post dilatation was carried out by a
8 mm balloon. Post stenting portal venogram showed
good flow through the graft into the IVC (Figure 4:B).
The portocaval gradient dropped to < 5 mmHg post stent-
ing. Subsequently she was anticoagulated with warfarin.
The patient has been on regular follow up since then and
is asymptomatic for five years.
A. Narrowed IVC with non visualization of hepatic veins Figure 1
A. Narrowed IVC with non visualization of hepatic 
veins. B. IVC stent in situ.
Percutaneous transhepatic venogram revealed left hepatic  vein replaced by multiple collaterals, IVC stent in situ Figure 2
Percutaneous transhepatic venogram revealed left 
hepatic vein replaced by multiple collaterals, IVC 
stent in situ.
Transjugular venogram A. Patent IVC Stent B. Narrowed  portocaval graft Figure 3
Transjugular venogram A. Patent IVC Stent B. Nar-
rowed portocaval graft.Cases Journal 2009, 2:1 http://www.casesjournal.com/content/2/1/1
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Discussion
BCS is characterized by manifestations of portal hyperten-
sion, inferior vena cava occlusion or both [1]. It produces
liver damage due to intense congestion, leading to devel-
opment of cirrhosis. To prevent congestion, various non-
surgical and surgical procedures have been described.
A variety of surgical procedures can be used for decom-
pression of the liver, including mesoatrial, mesocaval and
portocaval shunts and liver transplantation. If there is no
thrombosis in the inferior vena cava, a side-to-side porto-
caval shunt (SSPCS) is the procedure of choice in the early
and middle stages of the disease [2]. Direct portocaval
shunts have a thrombosis rate of 0.2%, compared with
occlusion rates 24–53% for mesocaval shunts with syn-
thetic grafts. However, autologous internal jugular vein
grafts have patency rates comparable with those of porto-
caval shunts [3]. Mesoatrial shunts are preferred if there is
a greater than 75% narrowing of the vena cava [4]. How-
ever, the patency rate of mesoatrial shunts is low, Slakey
et al. [5] reporting a primary shunt patency rate of only
46%. To improve the shunt patency Orloff et al. [2] intro-
duced a high-flow combination shunt, consisting of a
side-to side portocaval shunt and a cavoatrial shunt.
Results of this combined form were promising. Ortho-
topic liver transplantation is indicated in patients with
chronic BCS who have cirrhosis and patients with a failed
portosystemic shunt procedure. It has a 5-year survival
rate of 69% [6]. Blockage of the shunts performed to
decompress the liver can be a life-threatening event and is
usually associated with excessive variceal hemorrhage.
Recently percutaneous interventional techniques, includ-
ing angioplasty, fibrinolysis, Self expanding metallic
stents (SEMS) and TIPPS, have gained attention in the
treatment of BCS and shunt occlusion [7]. Angioplasty
has a high success rate in BCS due to congenital obstruc-
tion. For restenosis, balloon dilatation can be performed.
As angioplasty simulates intimal hyperplasia, the number
of balloon dilatations must be limited [7]. Xu et al. [8]
advocated the use of metallic stents for such angioplasty
failures. SEMS placement makes the dilatation more
definitive.
The drop in venous pressure is more marked and it keeps
the vessel patent for a longer time than angioplasty. But
growth of a hyperplastic intima around the wire may
reduce the diameter of the inferior vena cava. The stent
may also cross the outlet of the hepatic vein, which results
in an increase of turbulent flow and may lead to thrombo-
sis [9]. TIPPS can be performed in BCS patients to
improve the clinical condition while waiting for ortho-
topic liver transplantation. The TIPPS procedure is rela-
tively safe and effective but its long-term patency is
limited. Fortunately TIPPS stenosis responds well to
reinterventions such as balloon dilatation and stents [10].
There are limited cases in the literature of percutaneous
procedures secondary to a failed shunt, as most would
become eligible for transplant. In our patient, we placed a
SEMS in a narrowed portocaval shunt. As an interven-
tional procedure, SEMS produced a good long term result
with clinical improvement and patency. Therefore SEMS
could be the procedure of choice in occluded portocaval
shunts. We propose the use of SEMS as a salvage proce-
dure for blocked side to side portocaval H-grafts before
consideration of more radical procedures like liver trans-
plantation.
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